Another Drug Shows Potential for Functional Cures in Chronic Hepatitis B
(MedPage Today) -- Reductions in hepatitis B surface antigen (HBsAg) were observed with a novel small interfering RNA (siRNA) therapy in patients with chronic hepatitis B virus (HBV) infection, according to a phase II study. Among patients randomized...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.